{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:57:21Z","timestamp":1793033841466,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["NIHR131050"],"award-info":[{"award-number":["NIHR131050"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mandibular osteoradionecrosis (ORN) is a severe late radiation toxicity affecting 5\u201310% of patients who receive radiotherapy as part of treatment for head and neck malignancy. ORN can cause permanent disfigurement, dysfunction, pain and infection. There remains little robust evidence supporting the efficacy of medical or surgical management currently offered in clinical practice. Retrospective case series and meta-analyses of observational studies suggest that a repurposed triple drug combination pentoxifylline-tocopherol-clodronate (\u2018PENTOCLO\u2019) may be effective in preventing deterioration, promoting healing and ultimately reducing the need for major reconstructive surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The RAPTOR trial is a phase II, open-label, multicentre, randomised controlled trial with a superiority design. Eligible subjects with mandibular ORN are randomised 1:1 to receive standard of care (Arm A) or PENTOCLO plus standard of care (Arm B) for 12\u00a0months. The primary outcome measure is time from randomisation to healing of ORN (without the need for surgery), as measured by clinical examination (confirming completely healed oral mucosa), intra-oral clinical photographs and imaging. RAPTOR has an embedded translational sample collection and a methodological component exploring the use of electronic patient-reported outcome measures (ePROM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The RAPTOR trial is the first randomised controlled clinical trial of PENTOCLO in this clinical setting. The results of this phase II trial will provide robust preliminary evidence on its efficacy and inform the feasibility and appropriateness of a subsequent definitive trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>RAPTOR is registered with the ISRCTN registry effective date 11th November 2022: Clinical trial of the non-surgical management of radiotherapy damage to the lower jaw ISRCTN34217298, and also registered with the European Clinical Trials Database (Eudra-CT 2022\u2013000728-39).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-08966-9","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:04:14Z","timestamp":1753365854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RAPTOR: Randomised Controlled Trial of PENTOCLO (pentoxifylline-tocopherol-clodronate) in Mandibular Osteoradionecrosis\u2014study protocol for an open-label phase II randomised controlled superiority trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-4042","authenticated-orcid":false,"given":"Richard","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayten","family":"Basoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kanatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Killen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tangney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagtar","family":"Dhanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mererid","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"8966_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.oraloncology.2016.12.002","volume":"64","author":"R Shaw","year":"2017","unstructured":"Shaw R, Tesfaye B, Bickerstaff M, Silcocks P, Butterworth C. Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis). Oral Oncol. 2017;64:73\u20137.","journal-title":"Oral Oncol"},{"issue":"7","key":"8966_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clon.2016.03.002","volume":"28","author":"J Dhanda","year":"2016","unstructured":"Dhanda J, Pasquier D, Newman L, Shaw R. Current Concepts in Osteoradionecrosis after Head and Neck Radiotherapy. Clin Oncol (R Coll Radiol). 2016;28(7):459\u201366.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"8966_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bjoms.2018.03.009","volume":"56","author":"J Dhanda","year":"2018","unstructured":"Dhanda J, Rennie L, Shaw R. Current trends in the medical management of osteoradionecrosis using triple therapy. Br J Oral Maxillofac Surg. 2018;56(5):401\u20135.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"8966_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/hed.26957","volume":"44","author":"E Mayland","year":"2022","unstructured":"Mayland E, Curry JM, Wax MK, et al. Impact of preoperative and intraoperative management on outcomes in osteoradionecrosis requiring free flap reconstruction. Head Neck. 2022;44(3):698\u2013709.","journal-title":"Head Neck"},{"issue":"3","key":"8966_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijrobp.2019.02.044","volume":"104","author":"RJ Shaw","year":"2019","unstructured":"Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery. Int J Radiat Oncol Biol Phys. 2019;104(3):530\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"8966_CR6","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1200\/JCO.2004.09.006","volume":"22","author":"D Annane","year":"2004","unstructured":"Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol. 2004;22(24):4893\u2013900.","journal-title":"J Clin Oncol"},{"key":"8966_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2021.11.021","volume":"166","author":"LE Forner","year":"2022","unstructured":"Forner LE, Dieleman FJ, Shaw RJ, et al. Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. Radiother Oncol. 2022;166:137\u201344.","journal-title":"Radiother Oncol"},{"issue":"13","key":"8966_CR8","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1200\/JCO.2003.06.064","volume":"21","author":"S Delanian","year":"2003","unstructured":"Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21(13):2545\u201350.","journal-title":"J Clin Oncol"},{"issue":"3","key":"8966_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijrobp.2010.03.029","volume":"80","author":"S Delanian","year":"2011","unstructured":"Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011;80(3):832\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"8966_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","volume":"73","author":"S Delanian","year":"2004","unstructured":"Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73(2):119\u201331.","journal-title":"Radiother Oncol"},{"issue":"1","key":"8966_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00002826-200201000-00007","volume":"25","author":"B Horvath","year":"2002","unstructured":"Horvath B, Marton Z, Halmosi R, et al. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clin Neuropharmacol. 2002;25(1):37\u201342.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"8966_CR12","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1200\/JCO.2004.09.101","volume":"22","author":"P Okunieff","year":"2004","unstructured":"Okunieff P, Augustine E, Hicks JE, et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004;22(11):2207\u201313.","journal-title":"J Clin Oncol"},{"issue":"5","key":"8966_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.oooo.2018.02.004","volume":"125","author":"M Martos-Fernandez","year":"2018","unstructured":"Martos-Fernandez M, Saez-Barba M, Lopez-Lopez J, Estrugo-Devesa A, Balibrea-Del-Castillo JM, Bescos-Atin C. Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(5):431\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"8966_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijom.2018.08.007","volume":"48","author":"A Kolokythas","year":"2019","unstructured":"Kolokythas A, Rasmussen JT, Reardon J, Feng C. Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis. Int J Oral Maxillofac Surg. 2019;48(2):173\u201380.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"8966_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.radonc.2021.10.020","volume":"165","author":"RC Brooker","year":"2021","unstructured":"Brooker RC, Antczak P, Liloglou T, et al. Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy. Radiother Oncol. 2021;165:87\u201393.","journal-title":"Radiother Oncol"},{"issue":"11","key":"8966_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.oraloncology.2012.08.002","volume":"48","author":"N Ghazali","year":"2012","unstructured":"Ghazali N, Shaw RJ, Rogers SN, Risk JM. Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review. Oral Oncol. 2012;48(11):1090\u2013100.","journal-title":"Oral Oncol"},{"key":"8966_CR17","unstructured":"Centre RTLCT. RAPTOR Trial Homepage. https:\/\/raptorstudy.org.uk. Published 2024. Accessed 17 Dec 2024, 2024."},{"issue":"3","key":"8966_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/hed.10171","volume":"25","author":"K Notani","year":"2003","unstructured":"Notani K, Yamazaki Y, Kitada H, et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck. 2003;25(3):181\u20136.","journal-title":"Head Neck"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08966-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:53:38Z","timestamp":1757282018000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08966-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8966"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08966-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol has been reviewed and approved by Tyne & Wear South Research Ethics Committee REC reference: 22\/NE\/0195 and IRAS project ID: 1005271, dated 27 October 2022\/.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Model consent forms and related patient information sheet and GP information are appended as Appendices 2 and 3.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"None of the investigators or co-authors has any financial or other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"254"}}